Identification of the Novel HLA‐B*39:188 Allele by Next‐Generation Sequencing
HLA · 2025
DOI: 10.1111/tan.70443 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Yizhen He und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: Alleles, Exons, High-Throughput Nucleotide Sequencing, HLA-B39 Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: the Science Research Foundation of Zhejiang Healthy Bureau.
Abstract (Originalsprache)
HLA‐B*39:188 differs from HLA‐B*39:15 by a single nucleotide substitution at position 1043 C>T.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Lina Dong, Nanying Chen, Faming Zhu
Förderung
- the Science Research Foundation of Zhejiang Healthy Bureau
Zitieren
APA
He, Y., Dong, L., Chen, N., Zhang, W., & Zhu, F. (2025). Identification of the Novel HLA‐B*39:188 Allele by Next‐Generation Sequencing. HLA. https://doi.org/10.1111/tan.70443
Vancouver
He Y, Dong L, Chen N, Zhang W, Zhu F. Identification of the Novel HLA‐B*39:188 Allele by Next‐Generation Sequencing. HLA. 2025. doi:10.1111/tan.70443
BibTeX
@article{He2025,
author = {He, Yizhen and Dong, Lina and Chen, Nanying and Zhang, Wei and Zhu, Faming},
title = {Identification of the Novel HLA‐B*39:188 Allele by Next‐Generation Sequencing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70443}
}
EUVIMED